Guerbet SA (EPA:GBT)
9.23
+0.13 (1.43%)
Jun 23, 2026, 5:35 PM CET
Guerbet Market Cap
Guerbet has a market cap or net worth of €116.44 million as of June 23, 2026. Its market cap has decreased by -56.52% in one year.
Market Cap
116.44M
Enterprise Value
435.22M
Revenue
798.67M
Ranking
n/a
PE Ratio
n/a
Stock Price
€9.23
Market Cap Chart
Since March 3, 1992, Guerbet's market cap has decreased from 142.85M to 116.44M, a decrease of -18.49%. That is a compound annual growth rate of -0.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 116.44M | -35.38% |
| Dec 31, 2025 | 180.20M | -46.68% |
| Dec 31, 2024 | 337.92M | 37.29% |
| Dec 29, 2023 | 246.14M | 14.95% |
| Dec 30, 2022 | 214.13M | -54.42% |
| Dec 31, 2021 | 469.83M | 13.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eurobio Scientific Société anonyme | 223.52M |
| Carvolix | 209.72M |
| Median Technologies | 195.78M |
| Theraclion | 51.18M |
| Diagnostic Medical Systems | 32.91M |
| Mauna Kea Technologies | 29.62M |
| Novacyt | 28.95M |
| Implanet | 26.61M |